HK Inno.N’s ‘K-CAB Tab’ is the only drug that is applied the refund-type Price-Volume Agreement (PVA) system in Korea.

The fact that the system is only applied to homegrown new drugs, and some companies do not prefer double pricing caused by refunds are pointed to as reasons for the low utilization rate of the PVA system.

The National Health Insurance Service announced this at a training session organized by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) on the revision direction of the 'drug pricing negotiation guideline' and how to conduct drug pricing negotiations.

The refund-type PVA is a system that allows pharmaceutical companies to ma